Cancer mortality in nonsmoking women with smoking husbands based on a large-scale cohort study in Japan

doi:10.1016/S0091-7435(84)80017-1

Preventive Medicine

Volume 13, Issue 6, November 1984, Pages 680-690

https://doi.org/10.1016/S0091-7435(84)80017-1 Get rights and content

Mortality of 91,540 nonsmoking wives was studied in relation to the smoking habits of their husbands by means of a cohort study in Japan. During 16 years of follow-up, 200 deaths from lung cancer took place. The relative risks of lung cancer in these nonsmoking wives were 1.00, 1.36, 1.42, 1.58, and 1.91 when husbands were nonsmokers, ex-smokers, or daily smokers of 1–14, 15–19, or 20 or more cigarettes daily, respectively. Corresponding relative risks for stomach cancer were 1.00, 1.16, 1.00, 1.00, and 1.01, respectively. Specificity of association and internal consistencies were observed. Among cancers of each site, a similar tendency toward risk elevation in nonsmoking wives with smoking husbands was observed for nasal sinus cancer, brain tumors, and cancer of all sites besides lung cancer. In interpreting these results, the significance of proximity in exposure to sidestream smoke in Japanese homes was stressed.

References (11)

BosR.P. et al.
Excretion of mutagens in human urine after passive smoking
Cancer Lett
(1983)
CorreaP. et al.
Passive smoking and lung cancer
Lancet
(1983)
HirayamaT.
Passive smoking and lung cancer: Consistency of association
Lancet
(1983)
TrichopoulosD. et al.
Lung cancer and passive smoking; conclusion of Greek study
Lancet
(1983)
BrunnemannK.D. et al.
The influence of tobacco smoke on indoor atmospheres. II. Volatile and tobacco specific nitrosamines in main- and sidestream smoke and their contribution to indoor pollution

There are more references available in the full text version of this article.

Cited by (164)

Epidemiological evidence on environmental tobacco smoke and cancers other than lung or breast
2016, Regulatory Toxicology and Pharmacology
We reviewed 87 epidemiological studies relating environmental tobacco smoke (ETS) exposure to risk of cancer other than lung or breast in never smoking adults. This updates a 2002 review which also considered breast cancer. Meta-analysis showed no significant relationship with ETS for nasopharynx cancer, head and neck cancer, various digestive cancers (stomach, rectum, colorectal, liver, pancreas), or cancers of endometrium, ovary, bladder and brain. For some cancers (including oesophagus, colon, gall bladder and lymphoma) more limited data did not suggest a relationship. An increased cervix cancer risk (RR 1.58, 95%CI 1.29–1.93, n = 17 independent estimates), reducing to 1.29 (95%CI 1.01–1.65) after restriction to five estimates adjusting for HPV infection or sexual activity suggests a causal relationship, as do associations with nasosinus cancer observed in 2002 (no new studies since), and less so kidney cancer (RR 1.33, 95%CI 1.04–1.70, n = 6). A weaker association with total cancer (RR 1.13, 95%CI 1.03–1.35, n = 19) based on heterogeneous data is inconclusive. Inadequate confounder control, recall bias, publication bias, and occasional reports of implausibly large RRs in individual studies contribute to our conclusion that the epidemiological evidence does not convincingly demonstrate that ETS exposure causes any of the cancers studied.
SmokeHaz: Systematic Reviews and Meta-analyses of the Effects of Smoking on Respiratory Health
2016, Chest
Citation Excerpt :
A pooled analysis in the 13 comparisons from 11 studies10-12,16,25,26,31-33,35,37 that reported pack years found a significant dose response relationship between increasing risk (from threefold to 12-fold) of development of lung cancer with increasing exposure (< 20 pack years: RR, 3; 20-40 pack years: RR, 7; 40-60 pack years: RR, 11; > 60 pack years: RR, 12). Fifteen studies44-58 that assessed the effect of passive smoking on the risk of lung cancer were included in the review. Six (40%) were deemed to be of higher quality.
Smoking tobacco increases the risk of respiratory disease in adults and children, but communicating the magnitude of these effects in a scientific manner that is accessible and usable by the public and policymakers presents a challenge. We have therefore summarized scientific data on the impact of smoking on respiratory diseases to provide the content for a unique resource, SmokeHaz.
We conducted systematic reviews and meta-analyses of longitudinal studies (published to 2013) identified from electronic databases, gray literature, and experts. Random effect meta-analyses were used to pool the findings.
We included 216 articles. Among adult smokers, we confirmed substantially increased risks of lung cancer (risk ratio (RR), 10.92; 95% CI, 8.28-14.40; 34 studies), COPD (RR, 4.01; 95% CI, 3.18-5.05; 22 studies), and asthma (RR, 1.61; 95% CI, 1.07-2.42; eight studies). Exposure to passive smoke significantly increased the risk of lung cancer in adult nonsmokers and increased the risks of asthma, wheeze, lower respiratory infections, and reduced lung function in children. Smoking significantly increased the risk of sleep apnea and asthma exacerbations in adult and pregnant populations, and active and passive smoking increased the risk of tuberculosis.
These findings have been translated into easily digestible content and published on the SmokeHaz website.
Active and passive cigarette smoking and mortality among Hispanic and non-Hispanic white women diagnosed with invasive breast cancer
2015, Annals of Epidemiology
Citation Excerpt :
Data for breast cancer–specific mortality, however, are inconsistent, with reports of positive [12,17–23] or no [13,24–28] associations. No associations have been found between passive smoke exposure and breast cancer–specific mortality [27,29–31]. Several studies have evaluated whether prognostic factors, including disease stage and body mass index (BMI) [12,13,16,22,23], modify the association of smoking with breast cancer–specific mortality, but results are conflicting.
Women who smoke at breast cancer diagnosis have higher risk of breast cancer–specific and all-cause mortality than nonsmokers; however, differences by ethnicity or prognostic factors and risk for noncancer mortality have not been evaluated.
We examined associations of active and passive smoke exposure with mortality among Hispanic (n = 1020) and non-Hispanic white (n = 1198) women with invasive breast cancer in the Breast Cancer Health Disparities Study (median follow-up of 10.6 years).
Risk of breast cancer–specific (HR = 1.55, 95% CI = 1.11–2.16) and all-cause (HR = 1.68, 95% CI = 1.30–2.17) mortality was increased for current smokers, with similar results stratified by ethnicity. Ever smokers had an increased risk of noncancer mortality (HR = 1.68, 95% CI = 1.12–2.51). Associations were strongest for current smokers who smoked for 20 years or more were postmenopausal, overweight and/or obese, or reported moderate and/or high alcohol consumption; however, interactions were not significant. Breast cancer–specific mortality was increased two fold for moderate and/or high recent passive smoke exposure among never smokers (HR = 2.12, 95% CI = 1.24–3.63).
Findings support associations of active-smoking and passive-smoking diagnosis with risk of breast cancer–specific and all-cause mortality and ever smoking with noncancer mortality, regardless of ethnicity, and other factors. Smoking is a modifiable lifestyle factor and effective smoking cessation, and maintenance programs should be routinely recommended for women with breast cancer.
How do American and British Nonsmokers Value Secondhand Smoke Health Risks?
2024, Journal of Prevention
Health effects associated with exposure to secondhand smoke: a Burden of Proof study
2024, Nature Medicine
Epidemiology for Indoor Air Quality Problems
2022, Handbook of Indoor Air Quality

View all citing articles on Scopus

¹: Presented at the Symposium “Medical Perspectives on Passive Smoking,” April 9–12, 1984, Vienna, Austria.

View full text

Cancer mortality in nonsmoking women with smoking husbands based on a large-scale cohort study in Japan1

Cancer Lett

Lancet

Lancet

Lancet

The influence of tobacco smoke on indoor atmospheres. II. Volatile and tobacco specific nitrosamines in main- and sidestream smoke and their contribution to indoor pollution